Novonesis (Novozymes) A/S (NSIS-B) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.043x

Based on the latest financial reports, Novonesis (Novozymes) A/S (NSIS-B) has a cash flow conversion efficiency ratio of 0.043x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Dkr466.58 Million ≈ $73.00 Million USD) by net assets (Dkr10.74 Billion ≈ $1.68 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Novonesis (Novozymes) A/S - Cash Flow Conversion Efficiency Trend (2002–2024)

This chart illustrates how Novonesis (Novozymes) A/S's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Novonesis (Novozymes) A/S (NSIS-B) financial obligations for a breakdown of total debt and financial obligations.

Novonesis (Novozymes) A/S Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Novonesis (Novozymes) A/S ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
American Water Works
NYSE:AWK
0.070x
Cathay Financial Holding Co Ltd Pref A
TW:2882A
0.052x
Banco do Brasil S.A.
SA:BBAS3
0.201x
Swiss Life Holding AG
SW:SLHN
0.186x
Hyundai Electric & Energy Systems Co Ltd
KO:267260
0.116x
Willis Towers Watson PLC
NASDAQ:WTW
0.096x
LPL Financial Holdings Inc
NASDAQ:LPLA
0.124x
KUAISHOU TECHNOLOGY CL.B
F:5Y0
N/A

Annual Cash Flow Conversion Efficiency for Novonesis (Novozymes) A/S (2002–2024)

The table below shows the annual cash flow conversion efficiency of Novonesis (Novozymes) A/S from 2002 to 2024. For the full company profile with market capitalisation and key ratios, see market value of Novonesis (Novozymes) A/S.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 Dkr11.18 Billion
≈ $1.75 Billion
Dkr1.02 Billion
≈ $159.57 Million
0.091x -68.46%
2023-12-31 Dkr14.35 Billion
≈ $2.25 Billion
Dkr4.15 Billion
≈ $649.61 Million
0.289x +2.76%
2022-12-31 Dkr14.23 Billion
≈ $2.23 Billion
Dkr4.01 Billion
≈ $626.77 Million
0.282x -15.39%
2021-12-31 Dkr12.21 Billion
≈ $1.91 Billion
Dkr4.06 Billion
≈ $635.53 Million
0.333x -14.08%
2020-12-31 Dkr11.24 Billion
≈ $1.76 Billion
Dkr4.36 Billion
≈ $681.37 Million
0.387x +39.12%
2019-12-31 Dkr11.48 Billion
≈ $1.80 Billion
Dkr3.20 Billion
≈ $500.04 Million
0.278x -13.45%
2018-12-31 Dkr11.44 Billion
≈ $1.79 Billion
Dkr3.68 Billion
≈ $575.61 Million
0.322x -10.80%
2017-12-31 Dkr11.27 Billion
≈ $1.76 Billion
Dkr4.06 Billion
≈ $635.69 Million
0.361x +10.30%
2016-12-31 Dkr11.74 Billion
≈ $1.84 Billion
Dkr3.84 Billion
≈ $600.80 Million
0.327x +13.52%
2015-12-31 Dkr11.59 Billion
≈ $1.81 Billion
Dkr3.34 Billion
≈ $522.41 Million
0.288x -28.20%
2014-12-31 Dkr11.28 Billion
≈ $1.76 Billion
Dkr4.53 Billion
≈ $707.97 Million
0.401x +70.80%
2013-12-31 Dkr11.07 Billion
≈ $1.73 Billion
Dkr2.60 Billion
≈ $406.63 Million
0.235x -18.52%
2012-12-31 Dkr9.57 Billion
≈ $1.50 Billion
Dkr2.76 Billion
≈ $431.51 Million
0.288x -6.11%
2011-12-31 Dkr8.82 Billion
≈ $1.38 Billion
Dkr2.71 Billion
≈ $423.84 Million
0.307x +3.51%
2010-12-31 Dkr7.84 Billion
≈ $1.23 Billion
Dkr2.32 Billion
≈ $363.61 Million
0.297x -4.50%
2009-12-31 Dkr5.85 Billion
≈ $915.43 Million
Dkr1.82 Billion
≈ $284.28 Million
0.311x -18.09%
2008-12-31 Dkr4.48 Billion
≈ $700.30 Million
Dkr1.70 Billion
≈ $265.51 Million
0.379x -18.89%
2007-12-31 Dkr3.67 Billion
≈ $573.73 Million
Dkr1.71 Billion
≈ $268.17 Million
0.467x +3.39%
2006-12-31 Dkr3.39 Billion
≈ $530.86 Million
Dkr1.53 Billion
≈ $240.01 Million
0.452x +29.36%
2005-12-31 Dkr3.79 Billion
≈ $593.60 Million
Dkr1.33 Billion
≈ $207.46 Million
0.349x +5.69%
2004-12-31 Dkr3.89 Billion
≈ $608.93 Million
Dkr1.29 Billion
≈ $201.36 Million
0.331x +0.48%
2003-12-31 Dkr4.17 Billion
≈ $653.21 Million
Dkr1.37 Billion
≈ $214.97 Million
0.329x +18.38%
2002-12-31 Dkr4.25 Billion
≈ $664.63 Million
Dkr1.18 Billion
≈ $184.78 Million
0.278x --

About Novonesis (Novozymes) A/S

CO:NSIS-B Denmark Specialty Chemicals
Market Cap
$24.39 Billion
Dkr155.92 Billion DKK
Market Cap Rank
#1065 Global
#6 in Denmark
Share Price
Dkr378.50
Change (1 day)
+1.47%
52-Week Range
Dkr342.00 - Dkr487.30
All Time High
Dkr508.57
About

Novozymes A/S produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company provides biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as protein solutions and … Read more